No Data
No Data
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9
Geron (GERN) Receives a Buy From Barclays
Strong Growth and Strategic Financial Management Bolster Buy Rating for Geron's Promising Rytelo Drug
Stifel Maintains Geron(GERN.US) With Buy Rating
Unlock the Full List
102663425LV : Really.